T0	Participants 93 124	anemic cancer surgery patients.
T1	Participants 275 291	cancer patients.
T2	Participants 458 584	Twenty anemic sideropenic patients (hemoglobin </=110 g/l; serum iron <600 microg/l) with cancer of the gastrointestinal tract
T3	Participants 612 801	two groups: the first (n = 10) received 400 U/kg of r-Hu EPO divided in 4 doses (100 U/kg each, every 4 days); the second (n = 10) received 200 U/kg of r-HuEPO (50 U/kg each, every 4 days).
T4	Participants 1374 1409	anemic sideropenic cancer patients.